Akoya Biosciences マネジメント
マネジメント 基準チェック /34
Akoya Biosciencesの CEO はBrian McKelligonで、 Jul2017年に任命され、 の在任期間は 7.33年です。 の年間総報酬は$ 2.92Mで、 18.6%給与と81.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.075%を直接所有しており、その価値は$ 80.42K 。経営陣と取締役会の平均在任期間はそれぞれ3.1年と4.3年です。
主要情報
Brian McKelligon
最高経営責任者
US$2.9m
報酬総額
| CEO給与比率 | 18.6% |
| CEO在任期間 | 7.3yrs |
| CEOの所有権 | 0.08% |
| 経営陣の平均在職期間 | 3.1yrs |
| 取締役会の平均在任期間 | 4.3yrs |
経営陣の近況
Recent updates
Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA)
Nov 19
Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt?
Nov 12Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company
Oct 08Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target
Aug 09Market Might Still Lack Some Conviction On Akoya Biosciences, Inc. (NASDAQ:AKYA) Even After 31% Share Price Boost
Jun 27Is Akoya Biosciences (NASDAQ:AKYA) A Risky Investment?
Jun 24We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now
May 29Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)
May 10Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?
Feb 28Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump
Nov 25Akoya Biosciences Seeks Growth Despite Higher Operating Losses
May 30Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 11CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$58m |
| Jun 30 2024 | n/a | n/a | -US$60m |
| Mar 31 2024 | n/a | n/a | -US$68m |
| Dec 31 2023 | US$3m | US$543k | -US$63m |
| Sep 30 2023 | n/a | n/a | -US$71m |
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$73m |
| Dec 31 2022 | US$3m | US$518k | -US$71m |
| Sep 30 2022 | n/a | n/a | -US$69m |
| Jun 30 2022 | n/a | n/a | -US$63m |
| Mar 31 2022 | n/a | n/a | -US$51m |
| Dec 31 2021 | US$2m | US$393k | -US$44m |
| Sep 30 2021 | n/a | n/a | -US$34m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$516k | US$350k | -US$22m |
| Dec 31 2019 | US$484k | US$333k | -US$18m |
報酬と市場: Brianの 総報酬 ($USD 2.92M ) は、 US市場 ($USD 652.28K ) の同規模の企業の平均を上回っています。
報酬と収益: Brianの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Brian McKelligon (55 yo)
7.3yrs
在職期間
US$2,919,599
報酬
Mr. Brian McKelligon has been Chief Executive Officer and Director at Akoya Biosciences, Inc. since July 2017 and also serves as its President. Prior to joining Akoya, he led corporate and business develop...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 7.3yrs | US$2.92m | 0.075% $ 80.4k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 1.7yrs | US$2.37m | 0.092% $ 98.8k | |
| Senior Director of Business Development & Investor Relations Strategy | no data | データなし | データなし | |
| General Counsel | 1.8yrs | データなし | 0.012% $ 13.2k | |
| Chief Business Officer | 4.3yrs | US$365.22k | 0.29% $ 312.8k | |
| Senior Vice President | 3.1yrs | データなし | 0.17% $ 178.8k | |
| Secretary | no data | データなし | データなし |
3.1yrs
平均在職期間
51yo
平均年齢
経験豊富な経営陣: AKYAの経営陣は 経験豊富 であると考えられます ( 3.1年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 7.3yrs | US$2.92m | 0.075% $ 80.4k | |
| Independent Director | 9yrs | US$251.66k | 0.75% $ 798.3k | |
| Independent Director | 3.2yrs | US$237.50k | 0.040% $ 43.2k | |
| Independent Director | 5.2yrs | US$220.00k | 0% $ 0 | |
| Director | 9yrs | US$210.00k | 0.47% $ 506.7k | |
| Independent Director | 7.3yrs | US$232.50k | 1.99% $ 2.1m | |
| Member of Scientific Advisory Board | less than a year | データなし | データなし | |
| Independent Chairman | 3.4yrs | US$250.00k | 0.058% $ 61.6k | |
| Member of Scientific Advisory Board | less than a year | データなし | データなし | |
| Chair of the Scientific Advisory Board | less than a year | US$220.00k | 1.24% $ 1.3m |
4.3yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: AKYAの 取締役会 は 経験豊富 であると考えられます ( 4.3年の平均在任期間)。